FDA elevates Lay's potato chip recall in Oregon, Washington to highest risk level
Class I, according to the FDA, means exposure to or consumption of the product could cause "serious adverse health ...
FDA upgrades Oregon, Washington recall for Lay's Classic Potato Chips to highest level
The FDA upgraded a recall for Lay's Classic Potato Chips to the highest risk level for packages distributed in Oregon and ...
Spectrum News NY11d
Doctors for America sues CDC, FDA to restore health data removed from websites
The health care advocacy group said removing health information to comply with Trump's executive orders worsens medical care ...
The Washington Post3d
FDA approves new, non-opioid painkiller Journavx
The Food and Drug Administration on Thursday approved Journavx, a non-opioid painkiller that is the first novel pain drug to win government authorization in more than 20 years. Vertex ...
Truthout9d
Trump Aims to Overhaul the FDA. What Does That Mean for Public Health?
Meanwhile, in an executive order, Trump created his long-discussed “Department of Government Efficiency,” to be led by Elon ...
Lay’s recall of Classic Chips in 2 states classified at highest risk level, FDA warns it could cause 'death'
The FDA classified the recall of Lay's Classic Potato Chips in Oregon and Washington state as a Class 1 recall, which means ...
Washington Examiner5d
FDA approves painkiller designed to eliminate the risk of addiction associated with opioids
WASHINGTON (AP) — Federal officials on Thursday ... opioid medications like Vicodin and OxyContin. The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx ...
The Independent6d
FDA approves new painkiller that shows promise and challenges of opioid alternatives
Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today. From reproductive rights to climate change to Big Tech, The ...
USA Today6d
FDA upgrades Oregon, Washington recall for Lay's Classic Potato Chips to highest level
According to an FDA alert, packages delivered to Oregon and Washington as early as Nov. 3, 2024 “may contain undeclared milk” and “those with an allergy or severe sensitivity to milk run ...
FDA approves new painkiller that shows promise and challenges of opioid alternatives
The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often ...